Professor | Shuqing Chen | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Shuqing Chen
Contact Information	chenshuqing@zju.edu.cn
Language ability	English, Chinese
Province	Zhejiang

Upload Avatar (500 x 500)

Name

Shuqing Chen

Contact Information

chenshuqing@zju.edu.cn

Language ability

English, Chinese

Province

Zhejiang

University/Lab Affiliation and Title	Zhejiang University
Faculty	Pharmaceutical Sciences
Academic Background & Achievements	1983 - Bachelor of Science: Zhejiang Medical University 1987 - Master of Medicine: Zhejiang Medical University 1999 - Doctor of Medicine: Zhejiang University 1993.12-1995.8 - Visiting Scholar: University of Kentucky, USA 2001.1-2002.1 - Postdoctoral Research: Cornell University, USA
Work Experience	1983.8-1985.8 - Pharmacist: Yutao Zhangting Health Center, Zhejiang Province 1987.8-1990.10 - Assistant: Biochemistry Department, Zhejiang Medical University 1990.10-1993.12 - Lecturer: Biochemistry Department, Zhejiang Medical University 1995.8-1998.10 - Associate Professor: Biochemistry Department, Zhejiang University School of Medicine 1998.10-2003.3 - Professor, Vice Dean: Ningbo University School of Medicine 2003.4-present - Director, Professor, Doctoral Supervisor: Biotechnology Drug Research Laboratory, Zhejiang University School of Pharmacy
Awards	2016 - Outstanding Doctoral Dissertation Nomination: Research on the Design and Specific Antitumor Effects of TRAIL Conjugates 2015 - Second Prize, Higher Education Science and Technology Progress Award: Research on Key Technologies and Models for ADMET Drug Evaluation 2014 - Second Prize, Chinese Pharmaceutical Association Science and Technology Award: Research on Key Technologies and Models for ADMET Drug Evaluation 2014 - Excellent Social Science Book Award: Pharmacogenomics - Application in Patient Care 2012 - Second Prize, Chinese Pharmaceutical Association Science and Technology Award: Research on Chiral Drug Analysis and Stereoselective Metabolism 2012 - Second Prize, Zhejiang Science and Technology Progress Award: Research on Chiral Drug Analysis and Metabolism 2007 - First Prize, Zhejiang Traditional Chinese Medicine Science and Technology Innovation Award: Research on Screening Technology Platform for Metabolic Activity of Traditional Chinese Medicine and Natural Drugs 2004 - First Prize, Zhejiang Medical and Health Science and Technology Innovation Award: Research on Clinical Value of Drug Metabolizing Enzyme Genotypes 2004 - Second Prize, Zhejiang Science and Technology Progress Award: Research on Clinical Value of Drug Metabolizing Enzyme Genotypes 2000 - Second Prize, Ningbo University Teaching Achievement Award: Role of General Medicine in Higher Medical Education 1999 - Third Prize, Zhejiang Medical Science and Technology Progress Award: Identification and Detection Method of Tumor Susceptibility Gene CYP2C19 1998 - Third Prize, Zhejiang Science and Technology Progress Award: Polymorphism of Cytochrome P450 2D6 Gene and Its Clinical Significance 1996 - Second Prize, Zhejiang Medical University Teaching Achievement Award: Reform and Practice of Biochemical Experiment Teaching 1993 - Second Prize, Zhejiang Medical University Teaching Achievement Award: Reform and Practice of Basic Medical Experiment Teaching

University/Lab Affiliation and Title

Zhejiang University

Faculty

Pharmaceutical Sciences

Academic Background & Achievements

1983 - Bachelor of Science: Zhejiang Medical University
1987 - Master of Medicine: Zhejiang Medical University
1999 - Doctor of Medicine: Zhejiang University
1993.12-1995.8 - Visiting Scholar: University of Kentucky, USA
2001.1-2002.1 - Postdoctoral Research: Cornell University, USA

Work Experience

1983.8-1985.8 - Pharmacist: Yutao Zhangting Health Center, Zhejiang Province
1987.8-1990.10 - Assistant: Biochemistry Department, Zhejiang Medical University
1990.10-1993.12 - Lecturer: Biochemistry Department, Zhejiang Medical University
1995.8-1998.10 - Associate Professor: Biochemistry Department, Zhejiang University School of Medicine
1998.10-2003.3 - Professor, Vice Dean: Ningbo University School of Medicine
2003.4-present - Director, Professor, Doctoral Supervisor: Biotechnology Drug Research Laboratory, Zhejiang University School of Pharmacy

Awards

2016 - Outstanding Doctoral Dissertation Nomination: Research on the Design and Specific Antitumor Effects of TRAIL Conjugates
2015 - Second Prize, Higher Education Science and Technology Progress Award: Research on Key Technologies and Models for ADMET Drug Evaluation
2014 - Second Prize, Chinese Pharmaceutical Association Science and Technology Award: Research on Key Technologies and Models for ADMET Drug Evaluation
2014 - Excellent Social Science Book Award: Pharmacogenomics - Application in Patient Care
2012 - Second Prize, Chinese Pharmaceutical Association Science and Technology Award: Research on Chiral Drug Analysis and Stereoselective Metabolism
2012 - Second Prize, Zhejiang Science and Technology Progress Award: Research on Chiral Drug Analysis and Metabolism
2007 - First Prize, Zhejiang Traditional Chinese Medicine Science and Technology Innovation Award: Research on Screening Technology Platform for Metabolic Activity of Traditional Chinese Medicine and Natural Drugs
2004 - First Prize, Zhejiang Medical and Health Science and Technology Innovation Award: Research on Clinical Value of Drug Metabolizing Enzyme Genotypes
2004 - Second Prize, Zhejiang Science and Technology Progress Award: Research on Clinical Value of Drug Metabolizing Enzyme Genotypes
2000 - Second Prize, Ningbo University Teaching Achievement Award: Role of General Medicine in Higher Medical Education
1999 - Third Prize, Zhejiang Medical Science and Technology Progress Award: Identification and Detection Method of Tumor Susceptibility Gene CYP2C19
1998 - Third Prize, Zhejiang Science and Technology Progress Award: Polymorphism of Cytochrome P450 2D6 Gene and Its Clinical Significance
1996 - Second Prize, Zhejiang Medical University Teaching Achievement Award: Reform and Practice of Biochemical Experiment Teaching
1993 - Second Prize, Zhejiang Medical University Teaching Achievement Award: Reform and Practice of Basic Medical Experiment Teaching

Areas of Focus	Design of Novel Biotechnological Drugs New Technologies for Precision Medicine Based on Neoantigens
Publications	Emerging new therapeutic antibody derivatives for cancer treatment, Shijie Jin, Yanping Sun, Xiao Liang, Xinyu Gu, Jiangtao Ning, Yingchun Xu, Shuqing Chen, Liqiang Pan, 2021 Real-Time Imaging of Cell-Surface Proteins with Antibody-Based Fluorogenic Probes, Wenchao Wang, Ying Zhang, Hong Zhao, Xinlei Zhuang, Haoting Wang, Kaifeng He, Wanting Xu, Yu Kang, Shuqing Chen, Su Zeng, Linghui Qian, 2021 Optimization strategies for expression of a novel bifunctional anti-PD-L1/TGFBR2-ECD fusion protein, Zhang-zhao Gao, Cui Li, Gang Chen, Jun-jie Yuan, Ya-qiong Zhou, Jing-yu Jiao, Lei Nie, Jian Qi, Yong Yang, Shu-qing Chen, Hai-bin Wang, 2022 Development of a recombinant RBD subunit vaccine for SARS-CoV-2, Yi-sheng Sun, Jing Jing Zhou, Ping Han Zhu, Fang Xu, Wenbin Zhao, Hang-Jing Lu, Zhen Wang, Shuqing Chen, Ping-Ping Yao, Jianmin Jiang, Zhan Zhou, 2021 Facile generation of potent bispecific Fab via Sortase A and Click chemistry for cancer immunotherapy, Xuefei Bai, Wenhui Liu, Shijie Jin, Wenbin Zhao, Yingchun Xu, Zhan Zhou, Shuqing Chen, Liqiang Pan, 2021 TSNAD v2.0: a one-stop software solution for tumor-specific neoantigen detection, Zhan Zhou, Jingcheng Wu, Jianan Ren, Wenfan Chen, Wenyi Zhao, Xun Gu, Jian Wu, Shuqing Chen, 2021 CanDriS: posterior profiling of cancer-driving sites based on two-component evolutionary model, Wenyi Zhao, Jingwen Yang, Jingcheng Wu, Guoxing Cai, Yao Zhang, Jeffrey Haltom, Weijia Su, Michael J Dong, Shuqing Chen, Jian Wu, Zhan Zhou, Xun Gu, 2021 A neoantigen-based peptide vaccine for patients with advanced pancreatic cancer refractory to standard treatment, Zheling Chen, Shanshan Zhang, Ning Han, Jiahong Jiang, Yunyun Xu, Dongying Ma, Lantian Lu, Xiaojie Guo, Min Qiu, Qinxue Huang, Huimin Wang, Fan Mo, Shuqing Chen, Liu Yang, 2021 Soluble Expression of Fc-Fused T Cell Receptors Allows Yielding Novel Bispecific T Cell Engagers, Wen-Bin Zhao, Ying Shen, Wen-Hui Liu, Yi-Ming Li, Shi-Jie Jin, Ying-Chun Xu, Li-Qiang Pan, Zhan Zhou, Shu-Qing Chen, 2021 A novel biparatopic EGFR-targeting nanobody drug conjugate displays potent anticancer activity in solid tumor models, Jiansheng Fan, Xinlei Zhuang, Xiaoyue Yang, Yingchun Xu, Zhan Zhou, Liqiang Pan, Shuqing Chen, 2021 Synthetic Multi-epitope Neoantigen DNA Vaccine for Personalized Cancer Immunotherapy, Xiaoyue Yang, Jiansheng Fan, Zhiming Ma, Jin Huang, Ying Zhang, Zhan Zhou, Fan Mo, Xuerong Liu, Hong Yuan, Yingchun Xu, Liqiang Pan, Shuqing Chen, 2021 Multi-epitope vaccine design using an immunoinformatics approach for COVID-19, Ye Feng, Haiping Jiang, Min Qiu, Liang Liu, Shengmei Zou, Yun Li, Qianpeng Guo, Ning Han, Yingqiang Sun, Kui Wang, Xinlei Zhuang, Shanshan Zhang, Shuqing Chen, Fan Mo, 2021 A novel genomic classification system of gastric cancer via integrating multidimensional genomic characteristics, Haiyong Wang, Yongfeng Ding, Yanyan Chen, Junjie Jiang, Yiran Chen, Jun Lu, Mei Kong, Fan Mo, Yingying Huang, Wenyi Zhao, Ping Fang, Xiangliu Chen, Xiaodong Teng, Nong Xu, Yimin Lu, Xiongfei Yu, Zhongqi Li, Jing Zhang, Haohao Wang, Xuanwen Bao, Donghui Zhou, Tianhua Zhou, Zhan Zhou, Shuqing Chen, Lisong Teng, 2021 Specifically inhibit tumor growth by T cell receptor-drug conjugates targeting intracellular cancer-testis antigen NY-ESO-1/LAGE-1, Chi-Xiao Qiu, Xue-Fei Bai, Ying Shen,

Areas of Focus

Design of Novel Biotechnological Drugs
New Technologies for Precision Medicine Based on Neoantigens

Publications

Emerging new therapeutic antibody derivatives for cancer treatment, Shijie Jin, Yanping Sun, Xiao Liang, Xinyu Gu, Jiangtao Ning, Yingchun Xu, Shuqing Chen, Liqiang Pan, 2021
Real-Time Imaging of Cell-Surface Proteins with Antibody-Based Fluorogenic Probes, Wenchao Wang, Ying Zhang, Hong Zhao, Xinlei Zhuang, Haoting Wang, Kaifeng He, Wanting Xu, Yu Kang, Shuqing Chen, Su Zeng, Linghui Qian, 2021
Optimization strategies for expression of a novel bifunctional anti-PD-L1/TGFBR2-ECD fusion protein, Zhang-zhao Gao, Cui Li, Gang Chen, Jun-jie Yuan, Ya-qiong Zhou, Jing-yu Jiao, Lei Nie, Jian Qi, Yong Yang, Shu-qing Chen, Hai-bin Wang, 2022
Development of a recombinant RBD subunit vaccine for SARS-CoV-2, Yi-sheng Sun, Jing Jing Zhou, Ping Han Zhu, Fang Xu, Wenbin Zhao, Hang-Jing Lu, Zhen Wang, Shuqing Chen, Ping-Ping Yao, Jianmin Jiang, Zhan Zhou, 2021
Facile generation of potent bispecific Fab via Sortase A and Click chemistry for cancer immunotherapy, Xuefei Bai, Wenhui Liu, Shijie Jin, Wenbin Zhao, Yingchun Xu, Zhan Zhou, Shuqing Chen, Liqiang Pan, 2021
TSNAD v2.0: a one-stop software solution for tumor-specific neoantigen detection, Zhan Zhou, Jingcheng Wu, Jianan Ren, Wenfan Chen, Wenyi Zhao, Xun Gu, Jian Wu, Shuqing Chen, 2021
CanDriS: posterior profiling of cancer-driving sites based on two-component evolutionary model, Wenyi Zhao, Jingwen Yang, Jingcheng Wu, Guoxing Cai, Yao Zhang, Jeffrey Haltom, Weijia Su, Michael J Dong, Shuqing Chen, Jian Wu, Zhan Zhou, Xun Gu, 2021
A neoantigen-based peptide vaccine for patients with advanced pancreatic cancer refractory to standard treatment, Zheling Chen, Shanshan Zhang, Ning Han, Jiahong Jiang, Yunyun Xu, Dongying Ma, Lantian Lu, Xiaojie Guo, Min Qiu, Qinxue Huang, Huimin Wang, Fan Mo, Shuqing Chen, Liu Yang, 2021
Soluble Expression of Fc-Fused T Cell Receptors Allows Yielding Novel Bispecific T Cell Engagers, Wen-Bin Zhao, Ying Shen, Wen-Hui Liu, Yi-Ming Li, Shi-Jie Jin, Ying-Chun Xu, Li-Qiang Pan, Zhan Zhou, Shu-Qing Chen, 2021
A novel biparatopic EGFR-targeting nanobody drug conjugate displays potent anticancer activity in solid tumor models, Jiansheng Fan, Xinlei Zhuang, Xiaoyue Yang, Yingchun Xu, Zhan Zhou, Liqiang Pan, Shuqing Chen, 2021
Synthetic Multi-epitope Neoantigen DNA Vaccine for Personalized Cancer Immunotherapy, Xiaoyue Yang, Jiansheng Fan, Zhiming Ma, Jin Huang, Ying Zhang, Zhan Zhou, Fan Mo, Xuerong Liu, Hong Yuan, Yingchun Xu, Liqiang Pan, Shuqing Chen, 2021
Multi-epitope vaccine design using an immunoinformatics approach for COVID-19, Ye Feng, Haiping Jiang, Min Qiu, Liang Liu, Shengmei Zou, Yun Li, Qianpeng Guo, Ning Han, Yingqiang Sun, Kui Wang, Xinlei Zhuang, Shanshan Zhang, Shuqing Chen, Fan Mo, 2021
A novel genomic classification system of gastric cancer via integrating multidimensional genomic characteristics, Haiyong Wang, Yongfeng Ding, Yanyan Chen, Junjie Jiang, Yiran Chen, Jun Lu, Mei Kong, Fan Mo, Yingying Huang, Wenyi Zhao, Ping Fang, Xiangliu Chen, Xiaodong Teng, Nong Xu, Yimin Lu, Xiongfei Yu, Zhongqi Li, Jing Zhang, Haohao Wang, Xuanwen Bao, Donghui Zhou, Tianhua Zhou, Zhan Zhou, Shuqing Chen, Lisong Teng, 2021
Specifically inhibit tumor growth by T cell receptor-drug conjugates targeting intracellular cancer-testis antigen NY-ESO-1/LAGE-1, Chi-Xiao Qiu, Xue-Fei Bai, Ying Shen,

Biotechnology Drug Design Precision Medicine Neoantigens Cancer Treatment Therapeutic Antibodies Immunotherapy Genomics Proteomics Biochemistry

Ying Chen - Fudan University

Zhang Wei - Fudan University

Yanfen Wu - Peking University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us